Stoptussin Tablets 4 mg / 100 mg, # 20

Stopussin tab.

4mg / 100mg No. 20

Name ENG

STOPTUSSIN

Clinical and pharmacological group

Drug with antitussive and expectorant action

ATX code

Antitussives in combination with expectorant drugs

Dosage

4 mg / 100 mg

Structure

1 tablet contains: Active ingredients: butamirate citrate 4 mg

guaifenesin 100 mg

Excipients: colloidal silicon dioxide

mannitol

MCC

glyceryl tribegenate

magnesium stearate.

Indications

Dry cough and irritating cough of various etiologies (including with infectious and inflammatory diseases of the upper and lower respiratory tract).

Storage conditions and periods

Store in a dark place at a temperature of 10-25 ° C.

Shelf life 5 years

...

Contraindications

hypersensitivity to the components of the drug

myasthenia gravis

children up to 12 years old for tablets, up to 6 months for drops for oral administration

I trimester of pregnancy

lactation period.

INN / Active ingredient

Butamirate, Guaifenesin

Specifications

Category

Cough

,

Thinning phlegm

,

Expectorants

Scope of the drug

Respiratory system

Release form

Tablet

Manufacturer country

Czech

Package quantity, pcs

twenty

Scope of application

Pulmonology

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Teva

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antitussive + expectorant

Dosage form

Pills

Packaging

Box

Expiration date in days

1826

The target audience

Adult

Dosage (volume) of the substance in the preparation

butamirate citrate 4.0 mg

guaifenesin 100.0 mg

Package weight, g

15

Mode of application

:

Inside, after a meal. < br> The tablets are taken whole, without chewing, with a liquid (water, tea, fruit juice). < br> For adults and children over 12 years of age, the drug is dosed depending on the patient's body weight: less than 50 kg - 1 / 2 tablets 4 times a day

50–70 kg - 1 tablet 3 times a day

70–90 kg - 1.5 tablets 3 times a day

more than 90 kg - 1.5 tab.

4 times a day. < br> The interval between doses should be 4-6 hours. < br> < br>

Anatomical and therapeutic characteristics

:

R05FB02 Antitussives in combination with expectorant drugs